Steven M Rowe Selected Research

Steven M Rowe Research Topics

Disease

104	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 12/2006
18	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 10/2010
15	Inflammation (Inflammations) 11/2022 - 04/2008
11	Lung Diseases (Lung Disease) 11/2021 - 04/2008
10	Chronic Bronchitis 01/2022 - 02/2014
7	Rhinosinusitis 01/2022 - 09/2011
7	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2009
5	Infections 01/2022 - 07/2014
4	Dehydration (Water Stress) 01/2022 - 11/2018
3	Sinusitis 01/2022 - 01/2020
3	Dyspnea (Shortness of Breath) 01/2021 - 02/2014
3	Fibrosis (Cirrhosis) 01/2020 - 11/2018
3	Diarrhea 07/2019 - 03/2014
3	Emphysema 11/2018 - 08/2015
2	Cough 01/2022 - 01/2016
2	Bronchitis 01/2022 - 01/2017
2	Headache (Headaches) 11/2021 - 01/2021
2	Airway Obstruction (Choking) 10/2019 - 01/2016
2	Pancreatitis 07/2019 - 12/2013
2	Weight Gain 01/2019 - 03/2017
2	Lung Injury 11/2018 - 02/2014
2	Hypoxia (Hypoxemia) 01/2017 - 10/2013
1	COVID-19 01/2022
1	Hypertrophy 01/2022
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 02/2021
1	Respiratory Sounds (Crackle) 01/2021
1	Bronchial Spasm 01/2021
1	Nausea 01/2021
1	Asthma (Bronchial Asthma) 01/2021
1	Fatigue 01/2021
1	Synucleinopathies 01/2020
1	Persistent Infection 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020

Drug/Important Bio-Agent (IBA)

48	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022 - 12/2006
34	ivacaftorIBA 11/2022 - 11/2010
26	ChloridesIBA 01/2022 - 09/2011
15	SmokeIBA 01/2022 - 10/2010
12	Proteins (Proteins, Gene)FDA Link 11/2022 - 04/2008
11	Nonsense Codon (Nonsense Mutation)IBA 01/2021 - 07/2007
10	lumacaftorIBA 01/2022 - 01/2012
9	ivacaftor drug combination tezacaftorIBA 01/2022 - 11/2017
9	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2007
8	Pharmaceutical PreparationsIBA 01/2022 - 01/2009
6	elexacaftorIBA 01/2022 - 10/2018
5	Bicarbonates (Hydrogen Carbonate)IBA 01/2020 - 10/2013
4	Expectorants (Mucolytics)IBA 01/2022 - 12/2018
4	atalurenIBA 01/2020 - 01/2009
4	MucinsIBA 01/2020 - 12/2018
4	AnionsIBA 04/2019 - 07/2013
4	Ion Channels (Ion Channel)IBA 12/2018 - 01/2012
4	AminoglycosidesIBA 11/2011 - 07/2007
3	Epithelial Sodium ChannelsIBA 01/2022 - 10/2018
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2010
3	EnzymesIBA 01/2020 - 07/2019
2	acebilustatIBA 11/2021 - 01/2018
2	Chloride Channels (Chloride Channel)IBA 01/2021 - 07/2019
2	icenticaftorIBA 01/2021 - 01/2020
2	Antisense OligonucleotidesIBA 01/2021 - 01/2019
2	Terminator Codon (Termination Codon)IBA 01/2021 - 01/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 12/2006
2	Glutathione (Reduced Glutathione)IBA 01/2020 - 09/2007
2	tezacaftorIBA 11/2019 - 11/2017
2	CollagenIBA 11/2018 - 04/2008
2	Heme (Haem)IBA 11/2018 - 08/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 10/2017
2	Interleukin-8 (Interleukin 8)IBA 10/2017 - 06/2015
2	RoflumilastIBA 01/2017 - 03/2014
2	Phosphodiesterase 4 InhibitorsIBA 01/2017 - 03/2014
2	SodiumIBA 01/2017 - 07/2013
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2014 - 02/2014
2	Tobramycin (Nebcin)FDA LinkGeneric 07/2014 - 09/2007
2	HMGB1 Protein (HMG1)IBA 03/2010 - 10/2008
1	ProteomeIBA 11/2022
1	Aligeron (AS 2)IBA 01/2022
1	Glucosamine (Dona)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 01/2022
1	riociguatIBA 11/2021
1	leukotriene A4 hydrolaseIBA 11/2021
1	Hyaluronic Acid (Hyaluronan)IBA 02/2021
1	ColforsinIBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 11/2020
1	Protein AggregatesIBA 01/2020
1	p300-CBP-associated factorIBA 01/2020
1	NADPH Oxidase 4IBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2020
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2020
1	Volatile Fatty AcidsIBA 01/2020

Therapy/Procedure

27	Therapeutics 01/2022 - 12/2006
2	Aftercare (After-Treatment) 03/2017 - 03/2015
1	Mechanical Ventilators (Ventilator) 02/2021
1	Noninvasive Ventilation 02/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	High-Protein Diet 01/2020
1	Stents 01/2020